Fei Tong

1.1k citations
30 papers · 522 indexed · h-index 11
Topics
Cancer-related molecular mechanisms research (4 papers)Cancer survivorship and care (4 papers)interferon and immune responses (3 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports

In The Last Decade

Fei Tong

29 papers receiving 512 citations

Peers

Fei Tong
Comparison fields: 5 of 91
  • Infectious Diseases 210
  • Oncology 135
  • Molecular Biology 119
  • Neurology 99
  • Epidemiology 83
Replace Francesco Taus with:
Francesco Taus Italy
Katie McCarthy United States
Xiaoyu Hu China
Lauren A. Vaught United States
Gabriel Cohen United States
Laura M. Tanner Finland
R. Babela Slovakia
Leo Nicolai Germany
Jennifer Thompson United States
Rashmi Jain India
Fei Tong relative to Francesco Taus Italy Francesco Taus's profile →
Citations per field
00.5×11.8×
Francesco Taus · 1×
Citations per year

Countries citing papers authored by Fei Tong

Since Specialization
Citations

This map shows the geographic impact of Fei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Tong more than expected).

Fields of papers citing papers by Fei Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Tong. The network helps show where Fei Tong may publish in the future.

Co-authorship network of co-authors of Fei Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Tong. A scholar is included among the top collaborators of Fei Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Tong. Fei Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 4
5 9
6 13
7 2
8 31
9 7
10 2
11
Dehydroepiandrosterone inhibits vascular proliferation and inflammation by modulating the miR-486a-3p/NLRP3 axis.
4
12 9
13 25
14 17
15 7
16 5
17 176
18 5
19 76
20 1

About Fei Tong

Fei Tong is a scholar working on Oncology, Cancer Research and Complementary and alternative medicine, having authored 30 papers that have together received 522 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Cancer survivorship and care (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Infectious Diseases (210 citations), Neurology (99 citations) and Oncology (135 citations). Fei Tong has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Mingming Fei, Hui Guo, Jinquan Wang, Changcheng Zheng, Zhaohui Lu, Yangyang Fu, Dingyu Tan, Xuezhong Yu, Joseph Harold Walline and Jun Xu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026